Article Text

Download PDFPDF
Authors’ response
  1. G Van Assche1,
  2. J Verbeeck2,
  3. S Vermeire1,
  4. M Van Ranst2,
  5. P Rutgeerts1
  1. 1Division of Gastroenterology, Leuven University Hospital, Leuven, Belgium
  2. 2Laboratory of Clinical Virology, Rega Institute for Medical Research, Leuven, Belgium
  1. Professor P Rutgeerts, Division of Gastroenterology, University Hospital Leuven, Herestraat 49, BE-3000 Leuven, Belgium; Paul.Rutgeerts{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We have read with interest the letter by Pineton de Chambrun and colleagues. The letter reflected on our prospective study of JC viral loads in immunosuppressed patients with Crohn’s disease and in controls. We thank the colleagues from Lille for their interest in our work and for further exploring this difficult issue, which will be crucial for the further development of anti-integrin therapies to treat inflammatory disorders. In the five patients with human immunodeficiency virus (HIV) diagnosed with progressive multifocal leukoencephalopathy (PML), the authors could not detect JC viraemia in the months preceding the clinical diagnosis. This finding is in contrast with the case of PML we reported in a patient treated with …

View Full Text


  • Competing interests: None.

Linked Articles